`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________________________________________
`
`HOPEWELL PHARMA VENTURES, INC.,
`Petitioner,
`
`v.
`MERCK SERONO S.A.,
`
`Patent Owner.
`
`_________________________________________________
`
`Case IPR2023-00481
`Patent 8,377,903
`
`____________________________________________________
`
`PATENT OWNER’S OBJECTIONS TO PETITIONER’S ORAL HEARING
`DEMONSTRATIVES
`
`
`
`
`
`
`
`IPR2023-00481
`Patent Owner’s Objections to
`Petitioner’s Oral Hearing Demonstratives
`
`
`Pursuant to the Board’s May 21, 2024 Order Setting Oral Argument (Paper
`
`
`
`50), Patent Owner, Merck Serono S.A., and Petitioner, Hopewell Pharma Ventures,
`
`Inc., have met and conferred regarding objections to the demonstratives on June
`
`20, 2024. Patent Owner hereby submits the following objections to Petitioner’s
`
`demonstrative slides:
`
`1.
`
`Slide 41: Patent Owner objects to the Petitioner’s presentation of
`
`“Fed. Cir. precedent belies Merck’s contentions of new arguments” and citations to
`
`Corephotonics, Ltd. v. Apple Inc., 84 F.4th 990, 1008 (Fed. Cir. 2023) and
`
`Rembrandt Diagnostics, LP v. Alere, Inc., 76 F.4th 1376, 1385 (Fed. Cir. 2023) as
`
`improper new argument to Patent Owner’s sur-reply outside of the trial record.
`
`2.
`
`Slide 42: Patent Owner objects to Petitioner’s presentation of
`
`“Hopewell did not shift to a new obviousness theory to rely on Rice” as improper
`
`new argument to Patent Owner’s sur-reply outside of the trial record.
`
`3.
`
`Slide 43: Patent Owner objects to Petitioner’s presentation of
`
`“Hopewell did not introduce a new argument regarding Bodor’s bioavailability” as
`
`improper new argument to Patent Owner’s sur-reply outside of the trial record.
`
`
`
`
`2
`
`
`
`IPR2023-00481
`Patent Owner’s Objections to
`Petitioner’s Oral Hearing Demonstratives
`
`
`Slide 44: Patent Owner objects to Petitioner’s presentation of
`
`4.
`
`“Hopewell did not ‘revise’ its routine optimization argument” as improper new
`
`argument to Patent Owner’s sur-reply outside of the trial record.
`
`5.
`
`Slide 47: Patent Owner objects to Petitioner’s presentation of its
`
`demonstrative chart, which presents new rebuttal arguments not present in
`
`Petitioner’s chart provided in its Reply at 3-4; Patent Owner identifies by highlight
`
`the objectionable portions of Petitioner’s demonstrative slide 47 in Appendix A.
`
`Dated: June 21, 2024
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`/Emily R. Whelan/
`Emily R. Whelan (Reg. No. 50,391)
`Counsel for Patent Owner
`Wilmer Cutler Pickering Hale and Dorr
`LLP
`60 State Street
`Boston, MA 02109
`Tel. (617) 526-6567
`E-mail: emily.whelan@wilmerhale.com
`
`
`
`
`3
`
`
`
`IPR2023-00481
`Patent Owner’s Objections to
`Petitioner’s Oral Hearing Demonstratives
`
`
`
`
`
`
`
`
`
`
`
`
`APPENDIX A
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`IPR2023-00481
`Patent Owner’s Objections to
`Petitioner’s Oral Hearing Demonstratives
`
`
`
`
`
`5
`
`
`
`
`
`
`IPR2023-00481
`Patent Owner’s Objections to
`Petitioner’s Oral Hearing Demonstratives
`
`
`CERTIFICATE OF SERVICE
`
` hereby certify that on June 21, 2024, I caused a true and correct copy of the
`
` I
`
`below documents:
`
` Patent Owner’s Objections to Petitioner’s Oral Hearing
`
`Demonstratives
`
` Appendix A to Patent Owner’s Objections to Petitioner’s Oral
`
`Hearing Demonstratives
`
`to be served via e-mail, as consented to by Petitioner, to:
`
`eellison-PTAB@sternekessler.com
`opartington-PTAB@sternekessler.com
`cvira-PTAB@sternekessler.com
`jcrozendaal-PTAB@sternekessler.com
`cdashe-PTAB@sternekessler.com
`pkhanduri-PTAB@sternekessler.com
`tliu-PTAB@sternekessler.com
`mbond-PTAB@sternekessler.com
`PTAB@sternekessler.com
`
`
`By: /Cindy Kan/
`Cindy Kan (Reg. No. 76,385)
`Wilmer Cutler Pickering Hale and Dorr LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`Tel: (212) 295-6470
`E-mail: cindy.kan@wilmerhale.com
`6
`
`
`
`
`